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apid and applicable methods for Brucellosis diagnosis using
alidated test methods and standardized reagents. For the
ontrol of brucellosis at the national or local level, the
uffered Brucella antigen tests (Boats), i.e. the Rose Bengal
est (RBT) and the buffered plate agglutination test (BPAT),
s well as the ELISA and the FPA, are suitable screening
ests. Positive reactions should be retested using a suitable
onﬁrmatory and/or complementary strategy (OIE manual,
009). The OIE reference standards are those against which
ll other standards are compared and calibrated. These ref-
rence standards are all available to national reference
aboratories and should be used to establish secondary or
ational standards against which working standards can be
repared and used in the diagnostic laboratory for daily rou-
ine use. These sera have been developed and designated by
he OIE as International Standard Sera. The use of these pro-
otes international harmonisation of diagnostic testing and
ntigen standardisation.
Methods: Sudanese national standard antiserum equiva-
ent to OIEISS was produced and standardised from naturally
nfected cows with a high titre of Brucella according to
eterinary laboratory agency-Webridge Laboratory methods
Hendry et al., 1985) and OIE manual (OIE, 2009). Apanel of
aturally infected cows sera were tested for Brucella Agglu-
inins by RBT, SAT and ELISA.The selected sera and OIEISS
ere titrated, tested and compared with previously men-
ioned serological tests.
Results: An sterile pooled high titre sera were suc-
essfully prepared. The serum was diluted perfectly with
egative serum to match with the OIEISS titre which was
000 IU.
Conclusion: This study was result in production of stan-
ardized National standard antiserum for the ﬁrst time in
udan, when checked locally using the appropriate methods
f Veterinary laboratory agency-Webridge, but needs fur-
her quality control check in the specialist OIE reference
aboratories.
oi:10.1016/j.ijid.2010.02.430
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Background: It has become clear in the recent years
hat predictive biomarkers are becoming an integral part
f successful clinical management. Further, a lack of clear
iomarkers has created a real challenge in licensing biode-
ense therapeutics and vaccines. The study presented seeks
o develop tools for the discovery of new microRNA (miRNA)
iomarkers for infectious diseases using advanced compu-
ational tools coupled with high density microarrays and
nimal test facilities to ﬁnd novel miRNA markers of viral
nfection. The system is expected to be of utility to diag-
ostics and vaccine and therapeutics development.
r
dternational Congress on Infectious Diseases (ICID) Abstracts
Methods: Extant software developed for miRNA sequence
ining coupled with supercomputers has been used to ana-
yze the genomes of human, mouse, rhesus macaque, and
ll full-length viral genomes available to identify candidate
iRNAs that may be of utility for detecting viral infections
nd other perturbances of normal metabolic function. These
equences are being incorporated into high density microar-
ays that will be used to assess miRNA expression responses
rom humans, rhesus macaques, and mice for any infec-
ious agent. Initial tests will be conducted on healthy tissue
nd tissue infected with ﬁloviruses to determine miRNA
esponses speciﬁc to ﬁlovirus infection. This system can
lso be used for any other viral infection as well as other
etabolic disturbances not necessarily related to viral infec-
ion and for biomarker discovery related to therapeutics and
accine efﬁcacy testing. The research proposed also aims to
pply, for the ﬁrst time, an miRNA screening tool to discov-
ry of miRNA biomarkers for ﬁlovirus infection.
Results: We have thus far identiﬁed 20442 viral
re-miRNA sequences, and 124292, 90054, and 104037
re-miRNA sequences for humans, macaque, and mouse,
espectively.
Conclusion: Given our preliminary results, we are con-
dent that our experiments seeking to validate these
redicted miRNAs will yield novel markers of infection.
oi:10.1016/j.ijid.2010.02.431
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Background: Clinical differentiation of bacterial and
bacterial meningitis is difﬁcult even for experienced
linician, and current laboratory tests cannot distinguish
etween them accurately and rapidly. Therefore, we aimed
o study the role of Procalcitonin (PCT) in differentiating
acterial from abacterial meningitis.
Methods: Patients suspected of having meningitis admit-
ed to Alexandria Fever Hospital were included in the study.
SF and blood samples were collected. CSF samples were
ubjected to microscopic examination, and culture. Blood
amples were used to measure serum PCT level.
Results: Out of the 75 examined cases; equal percentages
42.7%) were deﬁnitely diagnosed as bacterial and abacterial
eningitis cases. Elevated PCT level was found in (81.3%) of
acterial meningitis versus (9.4%) of abacterial meningitis.
CT was the least method of diagnosis to be affected by
readmission antibiotic intake. PCT serum level had a sensi-
ivity of 80.6%, a speciﬁcity of 91.3%, a negative predictive
alue of 93.5%, and a positive predictive value of 75.0%.
Conclusion: Measurement of PCT blood level is a rapid,
imple and speciﬁc test and may be recommended in the
iagnosis of bacterial meningitis cases, especially those who
eceived antibiotic therapy before hospitalization.
oi:10.1016/j.ijid.2010.02.432
